Bixiye
P42-17 Addition of Drugs to Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2891 - 2900 ee natiijooyinka 3607
Bixiye
P77-17 Medicare Advantage Process for NOMNC Letter
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017
Bixiye
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2018
Bixiye
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P49-17 Two New Medicare Advantage Prescription Drug Products in 2018
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2017
Bixiye
P11-17 Pre-Admission Notification Requirement for Admissions Effective June 1, 2017
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 04, 2017
Bixiye
P76-17 Centurion moving to Blue Cross for Claims Administration Services
Taariikhda uu dhaqangalayo Barnaamijka: Des 07, 2017
Bixiye
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2018